VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $278,000 | +7.8% | 15,515 | -2.1% | 0.01% | 0.0% |
| Q2 2017 | $258,000 | -48.9% | 15,850 | -56.1% | 0.01% | -50.0% |
| Q1 2017 | $505,000 | -18.5% | 36,080 | -7.2% | 0.01% | -20.0% |
| Q4 2016 | $620,000 | +14.0% | 38,865 | +19.0% | 0.02% | +15.4% |
| Q3 2016 | $544,000 | +34.3% | 32,670 | -9.7% | 0.01% | +30.0% |
| Q2 2016 | $405,000 | +34.6% | 36,190 | +0.7% | 0.01% | +42.9% |
| Q1 2016 | $301,000 | -9.1% | 35,945 | +1.1% | 0.01% | -12.5% |
| Q4 2015 | $331,000 | -17.5% | 35,565 | 0.0% | 0.01% | -46.7% |
| Q3 2015 | $401,000 | – | 35,565 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |